Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
297
datasets available to search
ShareScore release 0.9.0
Dataset results
297 results for “young women”
Effect Of Biomechanical Stimulation On Skeletal Health In Adolescent And Young Women With Anorexia Nervosa
ClinicalTrials.gov study NCT01100567. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women
ClinicalTrials.gov study NCT00710593. IPD Sharing: Not stated. Countries: 2. Publications: 3.
NC Young Women's CoOp
ClinicalTrials.gov study NCT02965014. IPD Sharing: YES. Countries: 1. Publications: 5.
Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania
ClinicalTrials.gov study NCT06605053. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Influenza Vaccine Effectiveness of a Quadrivalent Vaccine in Pregnant Women and Young Infants, 2019-2020
ClinicalTrials.gov study NCT04723771. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Standardized Patient Encounters to Improve PrEP Counseling for Adolescent Girls and Young Women in Kenya
ClinicalTrials.gov study NCT03875950. IPD Sharing: YES. Countries: 1. Publications: 1.
Friendship Bench Mental Health Intervention for Adolescent Girls and Young Women in South African PrEP Delivery Settings
ClinicalTrials.gov study NCT05664490. IPD Sharing: YES. Countries: 1. Publications: 6.
Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18
ClinicalTrials.gov study NCT00196937. IPD Sharing: YES. Countries: 2. Publications: 6.
Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine
ClinicalTrials.gov study NCT00316706. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)
ClinicalTrials.gov study NCT03158220. IPD Sharing: YES. Countries: 6. Publications: 1.
Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.
ClinicalTrials.gov study NCT00231413. IPD Sharing: YES. Countries: 2. Publications: 1.
Spironolactone Therapy In Young Women With NASH
ClinicalTrials.gov study NCT03576755. IPD Sharing: NO. Countries: 1. Publications: 13.
Young Women's Health CoOp (Cooperative) in Cape Town
ClinicalTrials.gov study NCT02677025. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)
ClinicalTrials.gov study NCT03493542. IPD Sharing: YES. Countries: 1. Publications: 1.
A Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African Women
ClinicalTrials.gov study NCT04833127. IPD Sharing: NO. Countries: 1. Publications: 4.
Electronic Cigarette Use in Young Adult Men and Women
ClinicalTrials.gov study NCT03089541. IPD Sharing: NO. Countries: 1. Publications: 1.
Uptake of Human Papilloma Virus vaccine among young women living in fishing communities in Wakiso and Mukono districts, Uganda
Open the record for dataset details and reuse information.
Acceptability of short message service reminders as the support tool for PrEP adherence among young women in Mukono district, Uganda
Open the record for dataset details and reuse information.
Risky sexual behaviours and utilization of HIV testing services among the adolescent girls and young women aged between 15-24 years in Kibra Sub County, Nairobi County, Kenya
Open the record for dataset details and reuse information.
Data from: Outcome of breast cancer in Moroccan young women correlated to clinic-pathological features, risk factors and treatment: a comparative study of 716 cases in a single institution
Background: Breast cancer in young women is quite uncommon and shows more aggressive characteristics with major disparities between worldwide populations. Prognosis and outcome of breast cancer in young patients are widely studied, but still no consensus is available. Methods: We retrospectively included 716 cases of breast cancer women diagnosed in 2009 at the National Institute of Oncology of Rabat. Patients were divided into two groups according to their age: women aged ≤40 years (Group 1) and women aged >40 years (Group 2). Data were recorded from patients' medical files and analyzed using SPSS 13.0 software (IBM). Results: Young patients represent 24.9% of all patients with breast cancer. The comparison between the two groups displayed significant differences regarding nulliparity (p = 0.001) and progesterone receptor negativity (p = 0.01). Moreover, more progression (Metastases/Relapse) was registered in young women as compared to older women with breast cancer (p = 0.03). The estimated median follow-up period was 31 months. The 5-years Event-Free Survival (EFS) of patients with local disease was 64.6% in young women and 71.5% in older women with breast cancer (p = 0.04). Multivariate analysis in young women showed that nulliparity (HR: 7.2; 95%CI: 1.16–44.54; p = 0.03), T3 tumors (HR: 17.39; 95%CI: 1.74–173.34; p = 0.01) and negative PgR status (HR: 19.85; 95%CI: 1.07–366.54; p = 0.04) can be considered as risk factors for poorer event free survival while hormone therapy was associated with better EFS (HR: 0.11; 95%CI: 0.00–0.75; p = 0.03). In Group 2, multivariate analysis showed that patients with inflammatory breast cancer, N+ status, absence of radiotherapy, absence of chemotherapy, and absence of hormone therapy are at increased risk of recurrence. Conclusions: In Morocco, breast cancer is more frequent in young women as compared to western countries. Breast cancer in young women is more aggressive and is diagnosed late, leading to an intensive treatment. Moreover, the main factors associated with breast cancer development in young women would be hormonal and reproductive status. Analysis of other genetic biomarkers is needed to explain the high prevalence of breast cancer in young women to improve breast cancer management in Morocco
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.